Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases

Clinical trial NCT02616393 · COMPLETED

Trial details

NCT number: NCT02616393
Sponsor: Kadmon Corporation, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Leptomeningeal Metastases Brain Metastases

Start date: 2015-11-01
Primary completion: 2018-04-03
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.